A Comparative Analysis of the Stock Performance of Biontech, Moderna, and Pfizer (2020-2023)

Introduction

The global pandemic that began in 2020 has brought the biotechnology and pharmaceutical sectors into sharp focus. Three companies, in particular, Biontech, Moderna, and Pfizer, have been at the forefront of vaccine development and distribution. This report provides a comprehensive analysis of their stock performance from 2020 to 2023. The data used in this analysis is sourced from credible financial databases such as Bloomberg, Yahoo Finance, and Reuters.